Anika Therapeutics | ANIK

Anika Therapeutics traded at $22.28 this Tuesday July 5th, decreasing $0.23 or 1.02 percent since the previous trading session. Looking back, over the last four weeks, Anika Therapeutics lost 1.23 percent. Over the last 12 months, its price fell by 48.55 percent. Looking ahead, we forecast Anika Therapeutics to be priced at 21.90 by the end of this quarter and at 20.17 in one year, according to Trading Economics global macro models projections and analysts expectations.

Stock Price
22.80
Daily Change
1.29%
Yearly
-47.34%

Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

API Features Documentation Interested? Click here to contact us
Please Paste this Code in your Website
width
height
 Preview
Peers Price Day Year
Abbott 108.53 -1.69 -1.53% -8.66%
Acorda Therapeutics 0.48 -0.001 -0.15% -89.54%
Agenus 2.28 0.32 16.07% -57.71%
Agios Pharmaceuticals 24.78 1.42 6.08% -56.72%
Anika Therapeutics 22.80 0.29 1.29% -47.34%
Arrowhead Research 38.41 2.45 6.81% -39.10%
ChemoCentryx 25.61 -1.16 -4.32% 82.24%
Clovis Oncology 2.58 -0.28 -9.65% -53.94%
Enanta Pharmaceuticals 52.25 2.62 5.28% 19.51%
Halozyme Therapeutics 46.09 1.61 3.62% -0.22%
Heron Therapeutics 2.80 0.08 2.94% -80.58%
Integra LifeSciences 53.99 -1.02 -1.85% -21.72%
Immunogen 4.86 0.25 5.31% -22.32%
Insmed 20.75 -0.14 -0.67% -26.05%
J&J 176.60 -2.90 -1.62% 5.14%
Karyopharm Therapeutics 5.10 0.37 7.72% -49.60%
Ligand Pharmaceuticals 92.97 2.39 2.64% -27.85%
MacroGenics 3.16 0.11 3.44% -88.92%
Merit Medical Systems 53.45 -1.51 -2.75% -16.06%
Peregrine Pharmaceuticals 16.04 0.71 4.66% -39.48%
Rigel Pharmaceuticals 1.25 0 0% -71.72%
Sanofi 97.12 -1.22 -1.24% 11.93%
Sangamo BioSciences 4.55 0.27 6.31% -59.56%
Smith & Nephew PLC 1,130.00 -10.00 -0.88% -28.91%
Surmodics 38.18 0.36 0.95% -28.69%
Stryker 200.49 -3.37 -1.65% -24.30%
Veracyte 22.67 1.57 7.44% -43.31%
Xencor 29.59 0.73 2.53% -14.33%
Intrexon 1.59 0.18 12.84% -74.58%
Zimmer Biomet Holdings Inc 106.11 -1.16 -1.08% -34.81%

Indexes Price Day Year
USND 11182 54.37 0.49% -23.74%
US2000 1716 -12.12 -0.70% -24.57%

Anika Therapeutics
Anika Therapeutics, Inc. is a joint preservation company. The Company creates and delivers advancements in early intervention orthopedic care, including in the areas of osteoarthritis (OA) pain management, regenerative solutions, soft tissue repair, and bone preserving joint technologies. It is focused on developing, manufacturing, and commercializing products based on its hyaluronic acid (HA) technology platform. Its product categories include joint pain management therapies, joint preservation and restoration care, and Other. The joint pain management therapies offer injectable viscosupplement products that provide pain relief from osteoarthritis conditions and its products include MONOVISC, ORTHOVISC, CINGAL and HYVISC. Its joint preservation and restoration care products include HYALOFAST and TACTOSET. Its Other product family consists of Hyalobarrier and Hyaloglide.